HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,420 | +5.9% | 8,100 | 0.0% | 0.03% | +11.5% |
| Q2 2023 | $292,167 | -5.6% | 8,100 | 0.0% | 0.03% | -10.3% |
| Q1 2023 | $309,339 | -32.9% | 8,100 | 0.0% | 0.03% | -37.0% |
| Q4 2022 | $460,890 | +57.3% | 8,100 | +9.5% | 0.05% | +43.8% |
| Q3 2022 | $293,000 | -10.1% | 7,400 | 0.0% | 0.03% | -5.9% |
| Q2 2022 | $326,000 | +10.5% | 7,400 | 0.0% | 0.03% | +36.0% |
| Q1 2022 | $295,000 | -1.0% | 7,400 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $298,000 | -1.0% | 7,400 | 0.0% | 0.02% | -13.8% |
| Q3 2021 | $301,000 | -10.4% | 7,400 | 0.0% | 0.03% | +11.5% |
| Q2 2021 | $336,000 | +8.7% | 7,400 | 0.0% | 0.03% | -16.1% |
| Q1 2021 | $309,000 | -2.2% | 7,400 | 0.0% | 0.03% | -13.9% |
| Q4 2020 | $316,000 | – | 7,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |